-Reuters
Piper Sandler Initiates Coverage On Miromatrix Medical with Overweight Rating, Announces Price Target of $8
Piper Sandler analyst Matt O'Brien initiates coverage on Miromatrix Medical (NASDAQ:MIRO) with a Overweight rating and announces Price Target of $8.